Home › NDC Lookup › RxCUI directory › RxCUI 2123042

50 ML immune globulin intravenous (human) - slra 100 MG/ML Injection [Asceniv] — RxCUI 2123042

RxNorm drug concept · Semantic branded drug
RxCUI 2123042 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2123042
Official name50 ML immune globulin intravenous (human) - slra 100 MG/ML Injection [Asceniv]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asASCENIV 10 % per 50 ML Injection; ASCENIV 10 % in 50 ML Injection; 50 ML Asceniv 100 MG/ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)215 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Human Immunoglobulin G: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Think of it as a collection of protective proteins — called antibodies — that healthy donors have built up against many different germs. If your immune system can't make enough of...
  • What exactly is human immunoglobulin G and why do I need it?
  • It depends on the specific product your doctor prescribed. The IV versions — like Privigen, Asceniv, Qivigy, and Gammaplex — are infused into a vein, usually every 3 to 4 weeks. Hi...
  • How is it given, and how often will I need infusions?
📖 Read our full Human Immunoglobulin G guide →

🕸️ Concept Web — How 50 ML immune globulin intravenous (human) - slra... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML immune globulin intravenous (human) - slra 100 MG/ML Injection [Asceniv] RxCUI 2123042

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Immunoglobulin G 5666
    • Immune globulin intravenous (human) - slra 2123035
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Asceniv 2123038
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Immunoglobulin G Injection 1809031
    • Immune globulin intravenous (human) - slra Injection 2649109
    • Immunoglobulin G Injectable Product 1156296
    • Immune globulin intravenous (human) - slra Injectable Product 2660104
    • Immunoglobulin G Injection [Asceniv] 2123040
    • Immune globulin intravenous (human) - slra Injection [Asceniv] 2656829
    • Asceniv Injectable Product 2123041
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 50 ML immune globulin intravenous (human) - slra 100 MG/ML Injection SCD · 2123037
  • Immune globulin intravenous (human) - slra 100 MG/ML SCDC · 2123036
  • Immunoglobulin G Injection SCDF · 1809031
  • Immune globulin intravenous (human) - slra Injection SCDFP · 2649109
  • Immunoglobulin G Injectable Product SCDG · 1156296
  • Immune globulin intravenous (human) - slra Injectable Product SCDGP · 2660104

Brand-Name Concepts

  • Immune globulin intravenous (human) - slra 100 MG/ML [Asceniv] SBDC · 2123039
  • Immunoglobulin G Injection [Asceniv] SBDF · 2123040
  • Immune globulin intravenous (human) - slra Injection [Asceniv] SBDFP · 2656829
  • Asceniv Injectable Product SBDG · 2123041
  • Asceniv BN · 2123038

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2123042 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69800-0250-01 1 VIAL, SINGLE-USE in 1 CARTON (69800-0250-1) / 50 mL in 1... ASCENIV ADMA Biologics, Inc. 2019-04-01
Observed labelers: ADMA Biologics, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1554 Inj. asceniv 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.